These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14617860)

  • 1. [Octanhydroxamate of iron: synthesis, analysis and investigation of stability].
    Palma P; Sapragoniene M; Stankevicius A
    Medicina (Kaunas); 2003; 39 Suppl 2():55-9. PubMed ID: 14617860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis of hydroxamic acids and study of their complexes with iron (II) and (III) ions].
    Nenortiene P; Sapragoniene M; Stankevicius A
    Medicina (Kaunas); 2002; 38(7):744-51. PubMed ID: 12474660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of iron (III) chelates in oral treatment of anemia: solution properties and absorption of iron (III) acetohydroxamate in anemic rats.
    Brown DA; Chidambaram MV; Clarke JJ; McAleese DM
    Bioinorg Chem; 1978 Sep; 9(3):255-75. PubMed ID: 698284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of labeled hydroxamates during iron transport from hydroxamate-ion chelates.
    Arceneaux JE; Davis WB; Downer DN; Haydon AH; Byers BR
    J Bacteriol; 1973 Sep; 115(3):919-27. PubMed ID: 4199517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron amino acid chelates.
    Hertrampf E; Olivares M
    Int J Vitam Nutr Res; 2004 Nov; 74(6):435-43. PubMed ID: 15743019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic Hydroxamic Acid Analogues of Bacterial Siderophores as Iron-Complexing Agents prepared through the Castagnoli-Cushman Reaction of Unprotected Oximes.
    Bakulina O; Bannykh A; Dar'in D; Krasavin M
    Chemistry; 2017 Dec; 23(70):17667-17673. PubMed ID: 29072340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of (pyrrolidone-5-hydroxamato)iron (III) chelates.
    Pećar M; Kujundzić N; Pazman J
    J Pharm Sci; 1977 Mar; 66(3):330-3. PubMed ID: 845796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimeric and trimeric homo- and heteroleptic hydroxamic acid macrocycles formed using mixed-ligand Fe(III)-based metal-templated synthesis.
    Sresutharsan A; Tieu W; Richardson-Sanchez T; Soe CZ; Codd R
    J Inorg Biochem; 2017 Dec; 177():344-351. PubMed ID: 28797801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxamate recognition during iron transport from hydroxamate-ion chelates.
    Haydon AH; Davis WB; Arceneaux JE; Byers BR
    J Bacteriol; 1973 Sep; 115(3):912-8. PubMed ID: 4199516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin, is a mixed chelate-protein ternary complex involved in the mechanism of iron uptake by serum-transferrin in vitro?
    Pakdaman R; Abdallah FB; El Hage Chahine JM
    J Mol Biol; 1999 Nov; 293(5):1273-84. PubMed ID: 10547300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effect of the lysosomotrophic preparation rheopolyglucin in treating iron-deficient anemia with iron saccharate].
    Ageeva TA; Shkurupiĭ VA
    Biull Eksp Biol Med; 1994 Jul; 118(7):40-3. PubMed ID: 7522618
    [No Abstract]   [Full Text] [Related]  

  • 12. Benzyl and methyl fatty hydroxamic acids based on palm kernel oil as chelating agent for liquid-liquid iron(III) extraction.
    Haron MJ; Jahangirian H; Silong S; Yusof NA; Kassim A; Rafiee-Moghaddam R; Mahdavi B; Peyda M; Abdollahi Y; Amin J
    Int J Mol Sci; 2012; 13(2):2148-2159. PubMed ID: 22408444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of iron multi-amino acid chelate preparation in mice and human duodenal HuTu 80 cells.
    Kajarabille N; Brown C; Cucliciu A; Thapaliya G; Latunde-Dada GO
    Br J Nutr; 2017 Mar; 117(6):767-774. PubMed ID: 28452291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma membrane ferric reductase activity of iron-limited algal cells is inhibited by ferric chelators.
    Sonier MB; Weger HG
    Biometals; 2010 Dec; 23(6):1029-42. PubMed ID: 20508972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxamate iron complex with phenoloxidase activity acting on lignin and chlorolignins.
    Parra C; Santiago MF; Rodriguez J; Durán N
    Biochem Biophys Res Commun; 1998 Aug; 249(3):719-22. PubMed ID: 9731204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium iron (III) ethylenediaminetetraacetic acid synthesis to reduce iron deficiency globally.
    Loots du T; van Lieshout M; Lachmann G
    Eur J Clin Nutr; 2007 Feb; 61(2):287-9. PubMed ID: 16885931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxamic acid-containing hydrogels for nonabsorbed iron chelation therapy: synthesis, characterization, and biological evaluation.
    Polomoscanik SC; Cannon CP; Neenan TX; Holmes-Farley SR; Mandeville WH; Dhal PK
    Biomacromolecules; 2005; 6(6):2946-53. PubMed ID: 16283713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a new hydroxamic acid from Pseudomonas mildenbergii.
    Hulcher FH
    Biochemistry; 1982 Aug; 21(18):4491-5. PubMed ID: 7126553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron deficiency anemia treatment response to oral iron therapy: a pooled analysis of five randomized controlled trials.
    Okam MM; Koch TA; Tran MH
    Haematologica; 2016 Jan; 101(1):e6-7. PubMed ID: 26518747
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanoparticulate iron(III) oxo-hydroxide delivers safe iron that is well absorbed and utilised in humans.
    Pereira DI; Bruggraber SF; Faria N; Poots LK; Tagmount MA; Aslam MF; Frazer DM; Vulpe CD; Anderson GJ; Powell JJ
    Nanomedicine; 2014 Nov; 10(8):1877-86. PubMed ID: 24983890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.